{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T18:20:15Z","timestamp":1792434015634,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100022690","name":"JDRF","doi-asserted-by":"publisher","award":["2-SRA-2022-1156-S-B"],"award-info":[{"award-number":["2-SRA-2022-1156-S-B"]}],"id":[{"id":"10.13039\/100022690","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s00125-025-06362-1","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T17:13:31Z","timestamp":1739294011000},"page":"930-939","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Continuous glucose monitor metrics from five studies identify participants at risk for type 1 diabetes development"],"prefix":"10.1007","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5325-7200","authenticated-orcid":false,"given":"Peter","family":"Calhoun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5567-0026","authenticated-orcid":false,"given":"Charles","family":"Spanbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5931-9484","authenticated-orcid":false,"given":"Andrea K.","family":"Steck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6636-4048","authenticated-orcid":false,"given":"Brigitte I.","family":"Frohnert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6979-103X","authenticated-orcid":false,"given":"Mark A.","family":"Herman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8671-4527","authenticated-orcid":false,"given":"Bart","family":"Keymeulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6557-270X","authenticated-orcid":false,"given":"Riitta","family":"Veijola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2228-334X","authenticated-orcid":false,"given":"Jorma","family":"Toppari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9070-3882","authenticated-orcid":false,"given":"Aster","family":"Desouter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9007-6177","authenticated-orcid":false,"given":"Frans","family":"Gorus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8489-4782","authenticated-orcid":false,"given":"Mark","family":"Atkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9589-6011","authenticated-orcid":false,"given":"Darrell M.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0899-0918","authenticated-orcid":false,"given":"Susan","family":"Pietropaolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5194-8446","authenticated-orcid":false,"given":"Roy W.","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,11]]},"reference":[{"issue":"10","key":"6362_CR1","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.2337\/dc15-1419","volume":"38","author":"RA Insel","year":"2015","unstructured":"Insel RA, Dunne JL, Atkinson MA et al (2015) Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association. Diabetes Care 38(10):1964\u20131974. https:\/\/doi.org\/10.2337\/dc15-1419","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"6362_CR2","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.2337\/dc24-S002","volume":"47","author":"American Diabetes Association Professional Practice Committee","year":"2024","unstructured":"American Diabetes Association Professional Practice Committee (2024) 2. Diagnosis and classification of diabetes: standards of care in diabetes-2024. Diabetes Care 47(Suppl 1):S20\u2013S42. https:\/\/doi.org\/10.2337\/dc24-S002","journal-title":"Diabetes Care"},{"issue":"8","key":"6362_CR3","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.2337\/dc16-2228","volume":"40","author":"FK Gorus","year":"2017","unstructured":"Gorus FK, Balti EV, Messaaoui A et al (2017) Twenty-year progression rate to clinical onset according to autoantibody profile, age, and HLA-DQ genotype in a registry-based group of children and adults with a first-degree relative with type 1 diabetes. Diabetes Care 40(8):1065\u20131072. https:\/\/doi.org\/10.2337\/dc16-2228","journal-title":"Diabetes Care"},{"issue":"23","key":"6362_CR4","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1001\/jama.2013.6285","volume":"309","author":"AG Ziegler","year":"2013","unstructured":"Ziegler AG, Rewers M, Simell O et al (2013) Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. JAMA 309(23):2473\u20132479. https:\/\/doi.org\/10.1001\/jama.2013.6285","journal-title":"JAMA"},{"issue":"7","key":"6362_CR5","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.2337\/dc20-0389","volume":"44","author":"ET Jensen","year":"2021","unstructured":"Jensen ET, Stafford JM, Saydah S et al (2021) Increase in prevalence of diabetic ketoacidosis at diagnosis among youth with type 1 diabetes: the SEARCH for diabetes in youth study. Diabetes Care 44(7):1573\u20131578. https:\/\/doi.org\/10.2337\/dc20-0389","journal-title":"Diabetes Care"},{"key":"6362_CR6","unstructured":"Swedish National Diabetes Register (2020) Swediabkids Annual Report. Available from https:\/\/www.ndr.nu\/pdfs\/Annual_Report_Swediabkids_2020.pdf. Accessed 18 Sept 2024"},{"issue":"1","key":"6362_CR7","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2337\/dc19-0428","volume":"43","author":"GT Alonso","year":"2020","unstructured":"Alonso GT, Coakley A, Pyle L, Manseau K, Thomas S, Rewers A (2020) Diabetic ketoacidosis at diagnosis of type 1 diabetes in Colorado children, 2010\u20132017. Diabetes Care 43(1):117\u2013121. https:\/\/doi.org\/10.2337\/dc19-0428","journal-title":"Diabetes Care"},{"issue":"1","key":"6362_CR8","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1515\/cclm-2023-0234","volume":"62","author":"K Joshi","year":"2024","unstructured":"Joshi K, Harris M, Cotterill A et al (2024) Continuous glucose monitoring has an increasing role in pre-symptomatic type 1 diabetes: advantages, limitations, and comparisons with laboratory-based testing. Clin Chem Lab Med 62(1):41\u201349. https:\/\/doi.org\/10.1515\/cclm-2023-0234","journal-title":"Clin Chem Lab Med"},{"issue":"9","key":"6362_CR9","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1089\/dia.2023.0064","volume":"25","author":"E Montaser","year":"2023","unstructured":"Montaser E, Breton MD, Brown SA, DeBoer MD, Kovatchev B, Farhy LS (2023) Predicting immunological risk for stage 1 and stage 2 diabetes using a 1-week CGM home test, nocturnal glucose increments, and standardized liquid mixed meal breakfasts, with classification enhanced by machine learning. Diabetes Technol Ther 25(9):631\u2013642. https:\/\/doi.org\/10.1089\/dia.2023.0064","journal-title":"Diabetes Technol Ther"},{"issue":"2","key":"6362_CR10","doi-asserted-by":"publisher","first-page":"365","DOI":"10.2337\/dc21-0602","volume":"45","author":"AK Steck","year":"2022","unstructured":"Steck AK, Dong F, Geno Rasmussen C et al (2022) CGM metrics predict imminent progression to type 1 diabetes: Autoimmunity Screening for Kids (ASK) Study. Diabetes Care 45(2):365\u2013371. https:\/\/doi.org\/10.2337\/dc21-0602","journal-title":"Diabetes Care"},{"issue":"12","key":"6362_CR11","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1007\/s00125-015-3761-y","volume":"58","author":"A Van Dalem","year":"2015","unstructured":"Van Dalem A, Demeester S, Balti EV et al (2015) Relationship between glycaemic variability and hyperglycaemic clamp-derived functional variables in (impending) type 1 diabetes. Diabetologia 58(12):2753\u20132764. https:\/\/doi.org\/10.1007\/s00125-015-3761-y","journal-title":"Diabetologia"},{"issue":"7","key":"6362_CR12","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.2337\/dc13-2965","volume":"37","author":"AK Steck","year":"2014","unstructured":"Steck AK, Dong F, Taki I, Hoffman M, Klingensmith GJ, Rewers MJ (2014) Early hyperglycemia detected by continuous glucose monitoring in children at risk for type 1 diabetes. Diabetes Care 37(7):2031\u20132033. https:\/\/doi.org\/10.2337\/dc13-2965","journal-title":"Diabetes Care"},{"key":"6362_CR13","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.diabres.2016.07.027","volume":"120","author":"O Helminen","year":"2016","unstructured":"Helminen O, Pokka T, Tossavainen P, Ilonen J, Knip M, Veijola R (2016) Continuous glucose monitoring and HbA1c in the evaluation of glucose metabolism in children at high risk for type 1 diabetes mellitus. Diabetes Res Clin Pract 120:89\u201396. https:\/\/doi.org\/10.1016\/j.diabres.2016.07.027","journal-title":"Diabetes Res Clin Pract"},{"issue":"3","key":"6362_CR14","doi-asserted-by":"publisher","first-page":"526","DOI":"10.2337\/dc22-1297","volume":"46","author":"DM Wilson","year":"2023","unstructured":"Wilson DM, Pietropaolo SL, Acevedo-Calado M et al (2023) CGM metrics identify dysglycemic states in participants from the TrialNet pathway to prevention study. Diabetes care 46(3):526\u2013534. https:\/\/doi.org\/10.2337\/dc22-1297","journal-title":"Diabetes care"},{"key":"6362_CR15","volume-title":"Analysis of survival data","author":"DR Cox","year":"1984","unstructured":"Cox DR (1984) Analysis of survival data. Chapman & Hall, New York"},{"issue":"1","key":"6362_CR16","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3102\/10769986025001060","volume":"25","author":"Y Benjamini","year":"2000","unstructured":"Benjamini Y, Hochberg Y (2000) On the adaptive control of the false discovery rate in multiple testing with independent statistics. J Educ Behav Stat 25(1):60\u201383. https:\/\/doi.org\/10.3102\/10769986025001060","journal-title":"J Educ Behav Stat"},{"issue":"7","key":"6362_CR17","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.2337\/dc19-2003","volume":"43","author":"RB McQueen","year":"2020","unstructured":"McQueen RB, Geno Rasmussen C, Waugh K et al (2020) Cost and cost-effectiveness of large-scale screening for type 1 diabetes in Colorado. Diabetes Care 43(7):1496\u20131503. https:\/\/doi.org\/10.2337\/dc19-2003","journal-title":"Diabetes Care"},{"issue":"6","key":"6362_CR18","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.2337\/diacare.27.6.1399","volume":"27","author":"JM Barker","year":"2004","unstructured":"Barker JM, Goehrig SH, Barriga K et al (2004) Clinical characteristics of children diagnosed with type 1 diabetes through intensive screening and follow-up. Diabetes Care 27(6):1399\u20131404. https:\/\/doi.org\/10.2337\/diacare.27.6.1399","journal-title":"Diabetes Care"},{"issue":"5","key":"6362_CR19","doi-asserted-by":"publisher","first-page":"769","DOI":"10.2337\/dc08-1872","volume":"32","author":"TM Triolo","year":"2009","unstructured":"Triolo TM, Chase HP, Barker JM (2009) Diabetic subjects diagnosed through the Diabetes Prevention Trial-Type 1 (DPT-1) are often asymptomatic with normal A1C at diabetes onset. Diabetes Care 32(5):769\u2013773. https:\/\/doi.org\/10.2337\/dc08-1872","journal-title":"Diabetes Care"},{"issue":"11","key":"6362_CR20","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.2337\/dc11-1026","volume":"34","author":"H Elding Larsson","year":"2011","unstructured":"Elding Larsson H, Vehik K, Bell R et al (2011) Reduced prevalence of diabetic ketoacidosis at diagnosis of type 1 diabetes in young children participating in longitudinal follow-up. Diabetes Care 34(11):2347\u20132352. https:\/\/doi.org\/10.2337\/dc11-1026","journal-title":"Diabetes Care"},{"issue":"2","key":"6362_CR21","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/pedi.12066","volume":"15","author":"H Elding Larsson","year":"2014","unstructured":"Elding Larsson H, Vehik K, Gesualdo P et al (2014) Children followed in the TEDDY study are diagnosed with type 1 diabetes at an early stage of disease. Pediatr Diabetes 15(2):118\u2013126. https:\/\/doi.org\/10.1111\/pedi.12066","journal-title":"Pediatr Diabetes"},{"issue":"1","key":"6362_CR22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1210\/clinem\/dgad472","volume":"109","author":"A Ylescupidez","year":"2023","unstructured":"Ylescupidez A, Speake C, Pietropaolo SL et al (2023) OGTT metrics surpass continuous glucose monitoring data for T1D prediction in multiple-autoantibody-positive individuals. J Clin Endocrinol Metab 109(1):57\u201367. https:\/\/doi.org\/10.1210\/clinem\/dgad472","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"6362_CR23","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1007\/s00125-002-0949-8","volume":"45","author":"K Decochez","year":"2002","unstructured":"Decochez K, De Leeuw IH, Keymeulen B et al (2002) IA-2 autoantibodies predict impending type I diabetes in siblings of patients. Diabetologia 45(12):1658\u20131666. https:\/\/doi.org\/10.1007\/s00125-002-0949-8","journal-title":"Diabetologia"},{"issue":"3","key":"6362_CR24","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00125-009-1618-y","volume":"53","author":"J De Grijse","year":"2010","unstructured":"De Grijse J, Asanghanwa M, Nouthe B et al (2010) Predictive power of screening for antibodies against insulinoma-associated protein 2 beta (IA-2\u03b2) and zinc transporter-8 to select first-degree relatives of type 1 diabetic patients with risk of rapid progression to clinical onset of the disease: implications for prevention trials. Diabetologia 53(3):517\u2013524. https:\/\/doi.org\/10.1007\/s00125-009-1618-y","journal-title":"Diabetologia"},{"issue":"1","key":"6362_CR25","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s001250050648","volume":"40","author":"FK Gorus","year":"1997","unstructured":"Gorus FK, Goubert P, Semakula C et al (1997) IA-2-autoantibodies complement GAD65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings. The Belgian Diabetes Registry. Diabetologia 40(1):95\u201399. https:\/\/doi.org\/10.1007\/s001250050648","journal-title":"Diabetologia"},{"issue":"5","key":"6362_CR26","doi-asserted-by":"publisher","first-page":"808","DOI":"10.2337\/dc14-2426","volume":"38","author":"AK Steck","year":"2015","unstructured":"Steck AK, Vehik K, Bonifacio E et al (2015) Predictors of progression from the appearance of islet autoantibodies to early childhood diabetes: The Environmental Determinants of Diabetes in the Young (TEDDY). Diabetes Care 38(5):808\u2013813. https:\/\/doi.org\/10.2337\/dc14-2426","journal-title":"Diabetes Care"},{"issue":"9","key":"6362_CR27","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1111\/dme.12437","volume":"31","author":"D Dabelea","year":"2014","unstructured":"Dabelea D, Ma Y, Knowler WC et al (2014) Diabetes autoantibodies do not predict progression to diabetes in adults: the Diabetes Prevention Program. Diabetic Med 31(9):1064\u20131068. https:\/\/doi.org\/10.1111\/dme.12437","journal-title":"Diabetic Med"},{"issue":"1","key":"6362_CR28","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s40537-018-0143-6","volume":"5","author":"G Smith","year":"2018","unstructured":"Smith G (2018) Step away from stepwise. J Big Data 5(1):32. https:\/\/doi.org\/10.1186\/s40537-018-0143-6","journal-title":"J Big Data"},{"issue":"6","key":"6362_CR29","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.1097\/ms9.0000000000000894","volume":"85","author":"C Elendu","year":"2023","unstructured":"Elendu C, David JA, Udoyen AO et al (2023) Comprehensive review of diabetic ketoacidosis: an update. Ann Med Surg (Lond) 85(6):2802\u20132807. https:\/\/doi.org\/10.1097\/ms9.0000000000000894","journal-title":"Ann Med Surg (Lond)"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-025-06362-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00125-025-06362-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-025-06362-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T01:09:41Z","timestamp":1770772181000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00125-025-06362-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,11]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["6362"],"URL":"https:\/\/doi.org\/10.1007\/s00125-025-06362-1","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,11]]},"assertion":[{"value":"20 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Selected data were presented at the 84th meeting of the American Diabetes Association, 21\u201324 June 2024, Orlando, FL, USA.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Acknowledgements"}},{"value":"The datasets analysed during the current study are not publicly available due to participant confidentiality.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"Research reported in this publication was supported by Breakthrough T1D (formerly JDRF; Award number: 2-SRA-2022-1156-S-B). The content is solely the responsibility of the authors and does not necessarily represent the official views of Breakthrough T1D.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"BK, AD and FG report no personal financial disclosures but their institution has received study supplies from Medtronic and Dexcom. DMW reports funding from the NIH and Breakthrough T1D. RWB reports no personal financial disclosures but reports that his institution has received funding on his behalf as follows: grant funding and study supplies from Tandem Diabetes Care, Beta Bionics, and Dexcom; study supplies from Medtronic, Ascencia and Roche; consulting fees and study supplies from Eli Lilly and Novo Nordisk; and consulting fees from Insulet, Bigfoot Biomedical, vTv Therapeutics and Diasome. PC, CS, AKS, BIF, MAH, RV, JT, MA and SP declare that there are no relationships or activities that might bias, or be perceived to bias, their work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 relationships and activities"}},{"value":"PC researched and interpreted the data and wrote the manuscript. CS performed statistical analysis and contributed to writing and reviewed the manuscript. AKS, BIF, MAH, BK, RV, JT, AD, FG, MA, DMW, SP and RWB researched data, contributed to the discussion and reviewed\/edited the manuscript. All authors reviewed the work critically for important intellectual content and approved the final version submitted for publication. PC is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Contribution statement"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}